Recognizing the benefits of economic evaluations as a tool to inform public health policy, the Bill and Melinda Gates Foundation (BMGF) in collaboration with the Tufts Medical Center has endeavored to aid in creating the tools, mechanisms, and frameworks to facilitate the generation of research, assessments, and evaluations globally. While the conc

The study suggests that the price of patented medicine in Thailand should be controlled based on equity pricing and outcome pricing. Equity pricing can be estimated from the international reference price and outcome pricing can be evaluated from therapeutic referencing or the pharmacoeconomic price. Moreover, in a case study of 7 medicines granted

Presently, Cost-Effectiveness Analysis has been increasingly adopted in health technology assessment. In addition, it is recognized as an important tool for policy makers in the health care resource allocation decision making process. However, the presentation of Cost-Effectiveness Analysis results in terms of cost per Quality-Adjusted Life Year (Q

By 2036, a staggering 5 billion people will lack access to healthcare if countries fail to increase their public health investment by at least 1% of their GDP. This is the prediction by the World Health Organization (WHO) since2019. While some believe achieving this funding incre

If we raise the word “addiction” to you, what are the things you are thinking of? Ecstasy? Methamphetamine? Cannabis? That is true. Addiction normally refers to drug addiction or substances that we take into our body and cause desire to retake it again. Addiction also harms both physical and mental

Sitaporn Youngkong MSc, PhD* * Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand This article provides an overview of the potential uses of health technology assessment (HTA) in health technology or health intervention-related policy decision-

Apirujee Punjataewakupt, PhD, earned her doctoral degree in pharmaceutical sciences from Chulalongkorn University. She has diverse experience in both the pharmaceutical industry and health-related research. She is currently serving as a research assistant at the Health Intervention and Technology Assessment Program (HITAP).Her expertise includes ph

EXECUTIVE SUMMARY This annual report has been prepared to compile and summarise the activities of the Health Intervention and Technology Assessment Program (HITAP) projects in the past year (2023). It highlights various initiatives aligned with HITAP’s vision, mission, and strategic pillars, guid

EXECUTIVE SUMMARY This annual report has been prepared to compile and summarise the activities of the Health Intervention and Technology Assessment Program (HITAP) projects in the past year (2023). It highlights various initiatives aligned with HITAP’s vision, mission, and strategic pillars, guid

(Reuters) – Republican governors bent on rejecting the healthcare law’s expanded insurance coverage for millions of low-income Americans may see their gambit backfire if their party fails to sweep the November elections.Five governors have vowed to opt out of the Medicaid expansion for low-income pe